Trexquant Investment LP Supernus Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

$8.01 Billion
Q1 2025

A detailed history of Trexquant Investment LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 144,494 shares of SUPN stock, worth $4.69 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

144,494

Previous 74,275 94.54%

Holding current value

$4.69 Million

Previous $2.69 Million 76.24%

% of portfolio

0.06%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$31.17 - $40.0 $2.19 Million - $2.81 Million	70,219 Added 94.54%	144,494 $4.73 Million
Q4 2024 Feb 12, 2025	SELL	$31.89 - $37.83 $659,389 - $782,210	-20,677 Reduced 21.78%	74,275 $2.69 Million
Q3 2024 Nov 12, 2024	BUY	$25.77 - $35.16 $2.45 Million - $3.34 Million	94,952 New	94,952 $2.96 Million
Q4 2023 Feb 09, 2024	SELL	$22.72 - $29.68 $270,072 - $352,806	-11,887 Reduced 39.61%	18,122 $524,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $479,442 - $572,304	17,390 Added 137.81%	30,009 $827,000
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $1.01 Million - $1.31 Million	-33,896 Reduced 72.87%	12,619 $379,000
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $798,325 - $960,595	22,855 Added 96.6%	46,515 $1.69 Million
Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $735,589 - $896,240	23,660 New	23,660 $843,000
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $283,751 - $378,375	-12,054 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$26.72 - $33.19 $322,082 - $400,072	12,054 New	12,054 $371,000
Q1 2021 May 13, 2021	SELL	$24.15 - $31.45 $257,197 - $334,942	-10,650 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$17.7 - $25.81 $188,505 - $274,876	10,650 New	10,650 $268,000
Q1 2020 May 08, 2020	SELL	$14.45 - $24.69 $156,522 - $267,442	-10,832 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$19.93 - $29.13 $215,881 - $315,536	10,832 New	10,832 $257,000
Q2 2019 Aug 09, 2019	SELL	$29.96 - $38.87 $2.48 Million - $3.22 Million	-82,901 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$32.77 - $41.99 $705,341 - $903,792	21,524 Added 35.07%	82,901 $2.91 Million
Q4 2018 Feb 13, 2019	BUY	$30.84 - $49.51 $1.89 Million - $3.04 Million	61,377 New	61,377 $2.04 Million
Q1 2018 May 03, 2018	SELL	$37.15 - $46.9 $534,662 - $674,984	-14,392 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$36.4 - $42.6 $523,868 - $613,099	14,392	14,392 $574,000

Others Institutions Holding SUPN

# of Institutions

305

Shares Held

60.8M

Call Options Held

8.8K

Put Options Held

6.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.74B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Supernus Pharmaceuticals, Inc. Transaction History